BILS Attend.

the Circle. bils.ai · BILS 2027 · Berlin

Your place
in the room.

10 and 11 February 2027.

Hotel Palace Berlin.

The conversations that matter.

Curated meetings · BILS 2027

You complete the form below. Three questions. Your challenges. Your priorities.

GBX Circle matches your profile to the organisations and leaders best placed to respond.

We send your curated meeting schedule before the room meets. You arrive prepared.

Hotel Palace Berlin · 10 and 11 February 2027

BILS 2027 · Attend

Attend.

The leaders who own the plant, sign the batch and carry the accountability are in this room.

Date

10 and 11 February 2027

Venue

Hotel Palace Berlin · Berlin

Format

Up to 150 leaders · 80/20 end-user · closed-door

Access

The conversations that matter.

Contact · Life Sciences

Herbert Ryan

Manager · Life Sciences · BILS

herbert@gbxcircle.com +44 204 572 7288

DetailsPassPaymentWelcome

First name

Last name

Organisation

Job title

Work email *

Direct line

Your pass

Nothing is charged here. Payment follows once your place is accepted.

How you join

Member

Enter

For your office

Optional. For an office that registers a leader, and for an invoice that must carry a purchase order.

Registering on behalf of a leader

Assistant name

Assistant email

Purchase order number

For the room

Three questions. Shapes who you sit with and what we prepare.

Current challenges

Select up to two

Process development and scale-up

Viral safety and biosafety

CMC and regulatory strategy

Single-use technology adoption

Manufacturing cost reduction

Other

Current investment areas

Select up to two

Downstream processing

Viral filtration and safety

Manufacturing automation

CDMO partnerships

Facility and capacity

Other

If you could meet one company or person at BILS, who would it be?

What decision are you making in the next six months?

What could you speak to from experience?

Which digital or AI technologies are you actively evaluating or deploying in bioprocess?

Select up to two

Digital twin · process simulation AI-driven process optimisation Process analytical technology (PAT) Electronic batch records · QMS Manufacturing execution systems (MES) Predictive maintenance None currently active

Where is your organisation's primary focus in supply chain quality assurance over the next 12 months?

Select one

CMO and CDMO qualification Raw material traceability and supply security Cold chain integrity and monitoring EMA Annex 1 and EU GMP compliance Digital quality systems · data integrity Risk-based supplier management Container closure integrity

What best describes your organisation's current investment posture in bioprocess technology?

Select one

Active procurement · decision within 6 months Pilot and evaluation stage Horizon planning · 12-24 months Strategic review · no immediate mandate Investment pause · reassessing priorities

What is your typical annual budget influence for technology, equipment and process investments?

Influence means decision authority or material input · not direct control alone

Up to £1M £1M to £10M £10M to £100M £100M to £1B+ Prefer not to disclose

Which virus removal filter do you currently use in your bioprocess?

Planova (Asahi Kasei) Viresolve Pro (Merck) Pegasus Prime (Pall) Virosart (Sartorius) Multiple / evaluating Not yet at this stage

What is your primary challenge in viral safety and filtration today?

Throughput and yield loss Regulatory compliance Scale-up to commercial Filter supply and sourcing Validation complexity Cost per batch

GBX Circle holds your details to review this request and to prepare the room. Privacy

the circle. · BILS 2027

Your placein the room.

Attend.

Noted.

Your place
in the room.